“Palivizumab Nella Profilassi Del Virus Respiratorio Sinciziale: Analisi Di Impatto Sul Budget Del SSN Italiano”. Farmeconomia. Health Economics and Therapeutic Pathways 12, no. 3S (July 15, 2011): 17–23. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/985.